Aging
Navigate
Submit an Article
Research Paper|Volume 11, Issue 20|pp. 9043–9059
T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma
Back to articleFigure 4(4 of 7)
100%
Figure 4
Figure 4.Cellular viability of glioblastoma cells treated with RSPO2 and AZD5363.
Figure 4 — T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma | Aging